vs
Side-by-side financial comparison of enCore Energy Corp. (EU) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $12.4M, roughly 1.1× enCore Energy Corp.). FENNEC PHARMACEUTICALS INC. runs the higher net margin — -34.7% vs -173.9%, a 139.2% gap on every dollar of revenue.
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
EU vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $13.8M |
| Net Profit | $-21.5M | $-4.8M |
| Gross Margin | 37.9% | — |
| Operating Margin | -135.9% | -18.5% |
| Net Margin | -173.9% | -34.7% |
| Revenue YoY | — | 73.8% |
| Net Profit YoY | — | -141.1% |
| EPS (diluted) | $-0.11 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.4M | $13.8M | ||
| Q3 25 | $8.9M | $12.5M | ||
| Q2 25 | $3.7M | $9.7M | ||
| Q1 25 | $18.2M | $8.8M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $25.4M |
| Q4 25 | $-21.5M | $-4.8M | ||
| Q3 25 | $-4.8M | $-638.0K | ||
| Q2 25 | $-6.3M | $-3.2M | ||
| Q1 25 | $-24.2M | $-1.2M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | — | ||
| Q2 25 | 30.8% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -135.9% | -18.5% | ||
| Q3 25 | -158.2% | -1.5% | ||
| Q2 25 | -526.1% | -28.3% | ||
| Q1 25 | -85.7% | -9.2% | ||
| Q4 24 | — | -11.8% | ||
| Q3 24 | — | -74.6% | ||
| Q2 24 | — | -69.4% | ||
| Q1 24 | — | 54.2% |
| Q4 25 | -173.9% | -34.7% | ||
| Q3 25 | -53.7% | -5.1% | ||
| Q2 25 | -172.7% | -32.7% | ||
| Q1 25 | -132.9% | -13.3% | ||
| Q4 24 | — | -25.0% | ||
| Q3 24 | — | -82.2% | ||
| Q2 24 | — | -76.5% | ||
| Q1 24 | — | 50.6% |
| Q4 25 | $-0.11 | $-0.17 | ||
| Q3 25 | $-0.03 | $-0.02 | ||
| Q2 25 | $-0.03 | $-0.11 | ||
| Q1 25 | $-0.13 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.21 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $36.8M |
| Total DebtLower is stronger | $110.0M | — |
| Stockholders' EquityBook value | $229.2M | $35.5M |
| Total Assets | $430.4M | $70.6M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $36.8M | ||
| Q3 25 | $91.9M | $21.9M | ||
| Q2 25 | $26.9M | $18.7M | ||
| Q1 25 | $29.7M | $22.7M | ||
| Q4 24 | — | $26.6M | ||
| Q3 24 | — | $40.3M | ||
| Q2 24 | — | $43.1M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $229.2M | $35.5M | ||
| Q3 25 | $248.6M | $-4.5M | ||
| Q2 25 | $264.7M | $-7.5M | ||
| Q1 25 | $267.9M | $-5.9M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | — | $-5.2M | ||
| Q2 24 | — | $-1.4M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | $430.4M | $70.6M | ||
| Q3 25 | $441.9M | $49.3M | ||
| Q2 25 | $359.4M | $44.9M | ||
| Q1 25 | $362.6M | $46.4M | ||
| Q4 24 | — | $44.9M | ||
| Q3 24 | — | $58.9M | ||
| Q2 24 | — | $63.2M | ||
| Q1 24 | — | $69.2M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.9M | $-6.0M |
| Free Cash FlowOCF − Capex | $7.2M | — |
| FCF MarginFCF / Revenue | 57.8% | — |
| Capex IntensityCapex / Revenue | 46.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.9M | $-6.0M | ||
| Q3 25 | $-20.3M | $1.5M | ||
| Q2 25 | $-9.9M | $-3.7M | ||
| Q1 25 | $-7.7M | $-4.3M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | — | $-2.2M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | — | $39.0M |
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | — | ||
| Q2 25 | $-14.1M | — | ||
| Q1 25 | $-11.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | — | ||
| Q2 25 | -385.2% | — | ||
| Q1 25 | -64.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 46.7% | — | ||
| Q3 25 | 68.0% | — | ||
| Q2 25 | 115.1% | — | ||
| Q1 25 | 21.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
